JEFFREY L TOKAR, M.D.
Osteopathic Medicine at Cottman Ave, Philadelphia, PA

License number
Pennsylvania MD424634
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
333 Cottman Ave, Philadelphia, PA 19111
Phone
(215) 728-6900
(215) 214-1425 (Fax)

Personal information

See more information about JEFFREY L TOKAR at radaris.com
Name
Address
Phone
Jeffrey L Tokar, age 53
200 Washington Ave, Philadelphia, PA 19106
(215) 923-7089
Jeffrey A Tokar, age 52
9800 Lake Rd, Lake City, PA 16423
(814) 774-4492
Jeffrey A Tokar, age 52
9800 Lake St, Lake City, PA 16423
(814) 774-4492
Jeffrey A Tokar, age 52
855 Napier Ave, Erie, PA 16511
Jeffrey A Tokar, age 51
702 Lake St, Girard, PA 16417

Professional information

Jeffrey L Tokar Photo 1

Dr. Jeffrey L Tokar, Philadelphia PA - MD (Doctor of Medicine)

Specialties:
Gastroenterology
Address:
333 Cottman Ave SUITE P3179, Philadelphia 19111
(215) 728-2570 (Phone)
Procedures:
Colonoscopy, Egd, Endoscopic Polypectomy, Endoscopic Ultrasonography-Eus, Gerd, Polyps, Sigmoidoscopy, Sigmoidoscopy-Flexible
Conditions:
Barrett's Esophagus, Colonoscopy, Digestive Diseases, Egd, Gastritis, Gerd, Pancreatic & Pancreatobiliary (Diseases & Disorders), Pancreatic Pseudocyst, Pancreatitis, Polyps, Sigmoidoscopy
Certifications:
Gastroenterology, 2004, Internal Medicine, 2000
Awards:
Healthgrades Honor Roll, Clinical T1 Micropapillary Urothelial Carcinoma Presenting with a Metastasis to the Pancreas., July 2011, Spiral enteroscopy: prospective U.S. multicenter study in patients with small-bowel disorders, Sept 2010, Temporary placement of covered self-expandable metal stents in benign biliary strictures: a new paradigm?, 2008, Small Bowel Cancers Diagnosed by Device-assisted Enteroscopy at a U.S. Referral Center: A Five-Year Experience, March 2011, Double-balloon enteroscopy in the elderly: safety, findings, and diagnostic and therapeutic success, March 2010, Proteomic Analyses of Pancreatic Cyst Fluids, 2009, Complications associated with Double Balloon Enteroscopy at 9 U.S. Centers, 2009, Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer., July 2012, Defining venous involvement in borderline resectable pancreatic cancer, Nov 2010, Use of an over-the-scope clipping device: multicenter retrospective results of the first U.S. experience (with videos)., July 2012, Fox Chase Cancer Center Web Site for Jeffrey L. Tokar, MD
Languages:
English, Russian
Hospitals:
333 Cottman Ave SUITE P3179, Philadelphia 19111
Temple University Hospital
3401 North Broad St, Philadelphia 19140
Fox Chase Cancer Center
333 Cottman Ave, Philadelphia 19111
Philosophy:
During my gastroenterology and hepatology fellowship at the University of Virginia, I became interested in 'interventional and therapeutic endoscopy.' I completed an extra year of training to learn how to perform advanced endoscopic procedures. These years of training further enhanced my knowledge and skill set, enabling me to provide highly specialized, yet individualized, care to patients with a wide variety of complex gastrointestinal problems. Patients with cancerous or precancerous conditions often benefit from endoscopic procedures. For example, these procedures can not only help diagnose cancers, but they can help prevent or even cure certain forms of cancer (sometimes eliminating the need for patients to undergo more invasive surgical procedures).
Education:
Medical School
SUNY Upstate Medical University (Syracuse)
State University Of Ny At Syracuse Health Sciences Center College Of Medicine
University Of Virginia Health System
State University Of New York At Albany


Jeffrey Tokar Photo 2

Biomarkers For The Diagnosis And Treatment Of Pancreatic Cancer

US Patent:
2011000, Jan 13, 2011
Filed:
Jan 21, 2009
Appl. No.:
12/812394
Inventors:
Anthony T. Yeung - Huntingdon Valley PA, US
Jeffrey Tokar - Philadelphia PA, US
International Classification:
G01N 33/68, G01N 33/543, C07H 21/04, C40B 40/10
US Classification:
436518, 436 87, 536 235, 506 18
Abstract:
Compositions and methods which indicate an increased risk for pancreatic carcinoma are disclosed.